/PRNewswire/ The global companion diagnostics market was worth US$ 5.24 Bn in 2020. It is likely to rise at a CAGR of 9% during the forecast period, from.
- Development of multiple companion diagnostics as well as biomarkers for lung cancer and increasing prevalence of cancer are likely to drive the expansion of the market expansion - Companion
/PRNewswire/ The global companion diagnostics market was worth US$ 5.24 Bn in 2020. It is likely to rise at a CAGR of 9% during the forecast period, from.